Expression of Inflammation-related Intercellular Adhesion Molecules in Cardiomyocytes In Vitro and Modulation by

Ibrahim El-Battrawy1, Erol Tülümen2, Siegfried Lang3

  • 1Division of Experimental Cardiology, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany German Center for Cardiovascular Research, Partner Site, Heidelberg-Mannheim, Mannheim, Germany Ibrahim.el-battrawy@medma.uni-heidelberg.de.

Insights

Human cardiomyocytes express inflammation-related cell adhesion molecules like CD31. Pro-inflammatory mediators, lipopolysaccharide (LPS) and thrombin, increased CD31 expression but not MADCAM1 or F11R.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Cell-surface adhesion molecules are crucial for intercellular processes and leukocyte transmigration during inflammation.
  • The expression of these molecules on cardiomyocytes and their response to inflammatory mediators were previously unknown.

Purpose of the Study:

  • To investigate the expression of specific cell-adhesion molecules on human cardiomyocytes.
  • To determine the effect of pro-inflammatory mediators (thrombin and lipopolysaccharide) on this expression.

Main Methods:

  • Primary human cardiomyocyte cultures were treated with thrombin, lipopolysaccharide (LPS), or both.
  • Expression of cell adhesion molecules (CD11a, CD11b, CD31, CD62P, CD162, F11 receptor, MADCAM1) was analyzed using flow cytometry.

Main Results:

  • Baseline expression was observed for CD31 (22.8%), MADCAM1 (7.1%), and F11R (2.6%) on human cardiomyocytes.
  • Thrombin and LPS significantly increased CD31 expression by 26% (p<0.05).
  • Neither mediator affected MADCAM1 or F11R expression.

Conclusions:

  • Human cardiomyocytes express inflammation-related cell adhesion molecules CD31, MADCAM1, and F11R in vitro.
  • Pro-inflammatory mediators LPS and thrombin enhance CD31 expression on cardiomyocytes.
  • MADCAM1 and F11R expression on cardiomyocytes remain unaffected by these inflammatory agents.
Abstract